Psychotherapeutic drugs market is
comprised of drugs which are used to treat mental illnesses such as confused
thinking, extreme mood swings, long lasting depression, social withdrawal and
suicidal thought. Commonly found mental disorders are schizophrenia, bipolar
disorder, anxiety and depression. Schizophrenia is a mental disease associated
with hearing voices, unorganized speech and broken thoughts. Depression is a
common disorder characterized by lack of confidence, pleasure and interest.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/psychotherapeutic-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The global Psychotherapeutic Drugs
Market is segmented on the basis of various therapeutic classes used to treat
mental illness such as antipsychotics (chlorpromazine, haloperidol),
antidepressants (amitriptyline, clomipramine), antimaniacs (lithium,
carbamazepine) and anxiety drugs (lorazepam, alprazolam). Antipsychotic is one
of the fastest growing segments owing to increasing incidences of mental
disorders such as schizophrenia and bipolar disorder. Atypical antipsychotics
are the most preferred antipsychotics because they are more efficacious than
first generation antipsychotics. Top selling antipsychotic drugs are Abilify,
Seroquel, Risperdal and Zyprexa.
The global psychotherapeutic drugs
market is growing worldwide due to high prevalence of emotional and mental
diseases. According to WHO report approximately 350 million people are
suffering from depression and around 24 million people are affected by
schizophrenia around the world as of today. Patent expiration of top psychotic
drugs Prozac, Geodon and Zyprexia has opened way for generic manufacturers and
it is expected that in coming years generic segment will rise dramatically and
will give rise price competition in the psychotherapeutic drugs market.
America has been the largest market
accounting for more than 40% of the total psychotherapeutic drugs market owing
to high incidences of schizophrenia and depression among baby boomers. It is
predicted that the market will witness rapid growth in Asia-Pacific under the
influence of changing life style, disease awareness and growing aging
population.
The key players operating in this
market are Eli Lilly, Bristol-Meyer Squibb, GlaxoSmithKline, Pfizer,
Astrazeneca, Astellas Pharma Inc., Wyeth and Johnson & Johnson.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172827
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment